Target Protein: AGPS/Alkyl-DHAP synthase
Immunogen Range: 31-130/658
Entrez Gene: 8540
Source: KLH conjugated synthetic peptide derived from human AGPS/Alkyl-DHAP synthase
Purification: Purified by Protein A.
Storage Buffer: Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.
Storage: Store at 4°C for 12 months.
Background: AGPS is a 658 amino acid enzyme that is required for glycerolipid metabolism and ether lipid biosynthesis. Localized to the inner aspect of the peroxisomal membrane, AGPS is likely part of a heterotrimeric complex that is also composed of GNPAT and a modified form of GNPAT. Containing one FAD-binding PCMH-type domain, AGPS utilizes FAD as a cofactor in the synthesis of alkyl-glycerone 3-phophate and a long-chain acid anion from 1-acteyl-glyerone 3-phosphate and a long-chain alcohol. Defects in the gene encoding AGPS results in rhizomelic chondrodysplasia punctata type 3, a disease characterized by vertebral disorders, severe mental retardation, cutaneous lesions, cataracts and rhizomelic shortening of the humerus and femur.
Predicted Molecular Weight: 67
Cross Reactive Species: Rat
Predicted Cross Reactive Species:
For research use only. Not intended for diagnostic or therapeutic use.